Here, we sought to conduct an in-depth site-specific characterization of Hp glycan composition in a cohort of patients with a variety of liver diseases, and early- and late-stage HCC, with the aim of reinforcing previous findings and to potentially reveal other unique glycopeptide structures with high value for the diagnosis of early-stage HCC. Here, HP is linked to liver disorder.